Regeneron Pharmaceuticals Business Finance Contracts & Agreements

106 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2025
Amendment No. 3 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Amendment No. 2 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Regeneron Pharmaceuticals, Inc. Restricted Stock Agreement for Executive Officers under 2014 Long-Term Incentive Plan
Equity Distribution Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2024
Waiver and Consent to Amended and Restated Employment Agreement between Regeneron Pharmaceuticals, Inc. and Leonard S. Schleifer, M.D., Ph.D.
Waiver Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Amendment No. 1 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Third Amended and Restated Guaranty Agreement by Regeneron Pharmaceuticals, Inc. and Subsidiaries, March 27, 2023
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Third Amended and Restated Participation Agreement among Old Saw Mill Holdings LLC, BA Leasing BSC, LLC, Bank of America, N.A., and Rent Assignees (March 27, 2023)
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Credit Agreement among Regeneron Pharmaceuticals, Inc., Subsidiaries, and JPMorgan Chase Bank, N.A. (December 19, 2022)
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Modification No. 06 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International (MCDC)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 04 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 03 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International for Large-Scale Manufacturing of COVID-19 Antibodies
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 02 to MCDC Base Agreement Between Regeneron Pharmaceuticals, Inc. and ATI
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 5 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 05 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 01 to MCDC Base Agreement Between Regeneron Pharmaceuticals, Inc. and ATI
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Second Amended and Restated Guaranty Agreement by Regeneron Pharmaceuticals, Inc. and Subsidiaries, March 2, 2022
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Second Amended and Restated Participation Agreement among Old Saw Mill Holdings LLC, BA Leasing BSC, LLC, Bank of America, N.A., and Rent Assignees (March 2, 2022)
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
First Amendment to Amended and Restated Participation Agreement among Old Saw Mill Holdings LLC, Regeneron Pharmaceuticals, Inc., BA Leasing BSC, LLC, Bank of America, N.A., and...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment No. 1 to Credit Agreement among Regeneron Pharmaceuticals, Inc., Affiliates, and JPMorgan Chase Bank, N.A.
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Modification No. 02 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification No. 01 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2021
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement with P. Roy Vagelos
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2021
First Supplemental Indenture to Indenture for Senior Notes between Regeneron Pharmaceuticals, Inc. and U.S. Bank National Association (August 12, 2020)
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Indenture Agreement between Regeneron Pharmaceuticals, Inc. and U.S. Bank National Association, dated August 12, 2020
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Underwriting Agreement for $2 Billion Senior Notes Offering by Regeneron Pharmaceuticals, Inc. and Underwriters
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Amendment No. 1 to Credit Agreement between Regeneron Pharmaceuticals, Inc. and Goldman Sachs Bank USA
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Credit Agreement among Regeneron Pharmaceuticals, Inc., Lenders, and Goldman Sachs Bank USA (May 25, 2020)
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Amendment to Investor Agreement between Regeneron Pharmaceuticals, Inc. and Sanofi (May 25, 2020)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Stock Repurchase Agreement between Regeneron Pharmaceuticals, Inc. and Sanofi dated May 25, 2020
Repurchase Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Regeneron Pharmaceuticals, Inc. Underwriting Agreement for Sale of Common Stock with BofA Securities, Goldman Sachs, Sanofi, and Aventisub LLC (May 26, 2020)
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Second Amendment Agreement to License and Collaboration Agreement between Regeneron Ireland DAC and Bayer Healthcare LLC
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Employee (Time-Based Vesting)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Description of Regeneron Pharmaceuticals, Inc. Common Stock and Registration Rights Agreement with Sanofi
Registration Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Stock Purchase Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. dated April 8, 2019
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
MA
2019
Investor Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. dated April 8, 2019
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
MA
2019